Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOW-DOSE: Low Dose Trimethoprim-Sulfamethoxazole for PCP
NCT04851015Phase 3Recruiting
- Start
- Nov 2025
- Primary completion
- Sep 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole in Pneumocystis jirovecii pneumonia (PJP). Started Nov 2025; status: recruiting.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
Pneumocystis jirovecii pneumonia (PJP)
Beyond the preview
Go deeper on NCT04851015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04851015.